greatest advances & unmet needs in aav downstream process development
Published 1 year ago • 20 plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
13:11
where are the greatest innovations yet to come for the aav field?
-
32:51
high titer adeno-associated virus (aav) production that is cost-effective and scalable
-
1:14:07
intro to functional magnetic resonance imagaging - part 2 - precision health bootcamp summer 2022
-
13:46
neuren pharmaceuticals ltd.: nnz-2591 as a potential treatment for angelman syndrome
-
38:40
practical strategies for overcoming challenges in the development of aav vectors for gene therapy
-
18:36
reducing the immunogenicity of aav through engineering the vector - george church
-
1:29
aav capsid engineering
-
55:44
ai, amps, and peptide discovery | exploration science
-
1:02:47
element biosciences webinar: accelerate your science with dna sequencing designed for you
-
4:31
neuren pharmaceuticals ceo jon pilcher on ausbiz
-
56:19
cost efficient manufacturing of purer aav gene therapy vectors
-
1:02:41
exploring possibilities for biotherapeutics in pharma 4 0
-
19:42
busted-ph: distinguish adaptive innovation... - avery selberg - evolcompgen - abstract - ismb 2022
-
9:14
boost your single cell studies with crisprclean and aviti™: sequence less and see more usable data
-
43:29
accelerating ar and it integration and innovation through interoperability
-
3:50
immunogenicity of aav-based gene therapies
-
42:51
enhancing efficiency and specificity with improved crispr components
-
55:51
directed evolution of next-generation aav vector systems for clinical gene therapy
-
9:20
how are advances in all genomics informing new treatment approaches?
-
51:15
early go-to-market considerations for cell & gene therapies
-
1:00:06
2022 life sciences moforum: day two